https://www.novartis.com/news/media-releases/novartis-investigational-iptacopan-phase-iii-study-demonstrates-clinically-meaningful-and-highly-statistically-significant-proteinuria-reduction-patients-iga-nephropathy-igan
https://www.biospace.com/article/novartis-pnh-trial-results-put-pressure-on-astrazeneca-s-ultomiris-and-soliris/
